We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Claudia Schmoor

Claudia Schmoor PhD

Research Associate, Head of Biometry and Data Management, Clinical Trials Unit, Faculty of Medicine and Medical Center – University of Freiburg, Freiburg, Germany

Disclosures

Dr. Schmoor received an institutional research grant from Boehringer Ingelheim to conduct the mediation analyses of the EMPA-REG OUTCOME trial.

Recent Contributions to PracticeUpdate:

  1. Cardiovascular Risk Reduction With Liraglutide